[HTML][HTML] COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities

K Bardosh, A Krug, E Jamrozik, T Lemmens… - Journal of Medical …, 2024 - jme.bmj.com
In 2022, students at North American universities with third-dose COVID-19 vaccine
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …

COVID-19 booster uptake among US adults: assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment

S Raman, D Kriner, N Ziebarth, K Simon… - Social Science & Medicine, 2022 - Elsevier
Objective Evidence shows that booster shots offer strong protection against the Omicron
variant of COVID-19. However, we know little about why individuals would receive a booster …

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

P Kardos, J Correia de Sousa, U Heininger… - Human Vaccines & …, 2024 - Taylor & Francis
Pertussis has several notable consequences, causing economic burden, increased strain on
healthcare facilities, and reductions in quality of life. Recent years have seen a trend toward …

A hierarchy of medical countermeasures against biological threats

AT Biggs, LF Littlejohn - Military medicine, 2022 - academic.oup.com
Introduction Emerging biological threats represent a serious challenge for force health
protection (FHP). Against a novel biological threat, medical countermeasures are the first …

[HTML][HTML] Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen …

P Pitisuttithum, J Dhitavat, C Sirivichayakul… - …, 2021 - thelancet.com
Background Recombinant pertussis vaccines inducing long-lasting immune responses
could help to control the rise in pertussis. We here report on persisting antibody responses 2 …

Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016

VD Bampoe, N Brown, L Deng, J Schiffer… - Clinical Infectious …, 2024 - academic.oup.com
Background Tetanus, a life-threatening infection, has become rare in the United States since
introduction of tetanus toxoid-containing vaccines (TTCVs), recommended as a childhood …

Herd immunity, vaccination and moral obligation

M Bullen, GS Heriot, E Jamrozik - Journal of Medical Ethics, 2023 - jme.bmj.com
The public health benefits of herd immunity are often used as the justification for coercive
vaccine policies. Yet,'herd immunity'as a term has multiple referents, which can result in …

Tetanus, analysis of 29 cases

A Pérez-González, I Fernández-Castro… - Medicina Clínica, 2022 - Elsevier
Background Tetanus disease is caused by Clostridium tetani, an anaerobe bacteria found in
dust and soil. Once reached human body through damaged tissues, C. tetani releases …

COVID-19 vaccine boosters for young adults: A risk-benefit assessment and five ethical arguments against mandates at universities

K Bardosh, A Krug, E Jamrozik… - Bardosh, K., Krug, A …, 2022 - papers.ssrn.com
Abstract Students at North American universities risk disenrollment due to third dose COVID-
19 vaccine mandates. We present a risk-benefit assessment of boosters in this age group …

[HTML][HTML] Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus …

L Fortuna, S Chaithongwongwatthana… - Vaccine, 2020 - Elsevier
A new generation of recombinant acellular pertussis vaccine containing genetically
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …